DUE TO RELATED PARTIES

9 Months Ended

Sep. 30, 2022

DUE TO RELATED PARTIES

Note 10 - DUE TO RELATED PARTIES

NOTE 10 – DUE TO RELATED PARTIES

Due to related parties consisted of the following:

	September 30,		December 31,
	2022		2021
	(Unaudited)
Ms. Huang Li (4)	$	54,848	$	61,492
Mr. Yang Wang (3)		404,933		92,719
Mr. Jun Wang (2)		583,107		439,449
World Precision Medicine Technology Inc. (1)		-		670,000
Total	$	1,042,888	$	1,263,660

(1)	World Precision Medicine Technology Inc. is controlled by Mr.. Cheung Ho Shun. Cheung Ho Shun purchased 152,284 ordinary shares of Platinum (now 1,754,997 shares of Yubo New York Class A common stock) on September 11, 2020 for $750,000 cash. On September 2, 2022, World Precision Medicine Technology, Inc. was issued 1,638,458 shares of Yubo New York Class A common stock in settlement of the Company’s due to World Precision Medicine Technology, Inc. then balance of $819,229.
(2)	Mr. Jun Wang controls 33.34% of the outstanding Class A common stock of Yubo New York and is the CEO of the Company and Yubo Beijing.
(3)	Mr. Yang Wang controls 20.85% of the outstanding Class A common stock of Yubo New York and is a director of the Company and Yubo Beijing.
(4)	Ms. Huang Li is a shareholder of Focus One Technology Group Limited (“Focus One”). Focus One owns 9.62% of the issued and outstanding Class A common stock of the Company.

The due to related parties payables are noninterest bearing and are due on demand.